Education

Medical School
Yale University School of Medicine (2010)
Internship
Memorial Sloan-Kettering Cancer Center (2011), Transitional Year
Residency
Memorial Sloan Kettering Cancer Center (2015), Radiation Oncology

Research Interest

  • Lymphoma: collaboration with other institutions to explore the role of radiotherapy in those with the recently defined double-hit lymphoma. In addition, Dr. Desai is the principal investigator on a trial at UTSW exploring combination of immunotherapy checkpoint blockade with total skin radiation therapy for advanced cutaneous lymphoma.
  • Prostate cancer: management of post-operative patients with recurrent disease, assessing the impact of androgen receptor variants on radiotherapy and hormone therapy for prostate cancer, and sexual function following radiotherapy.

Publications

Featured Publications LegendFeatured Publications

Androgen receptor variants mediate DNA repair after prostate cancer irradiation.
Yin Y, Li R, Xu K, Ding S, Li J, Baek G, Ramanand SG, Ding S, Liu Z, Gao Y, Kanchwala MS, Li X, Hutchinson R, Liu X, Woldu SL, Xing C, Desai NB, Feng FY, Burma S, de Bono JS, Dehm SM, Mani RS, Chen BPC, Raj GV Cancer Res. 2017 Jul
Erectile Function after Stereotactic Body Radiotherapy for Localized Prostate Cancer.
Dess RT, Hartman HE, Aghdam N, Jackson WC, Soni PD, Abugharib AE, Suy S, Desai NB, Zumsteg ZS, Mehra R, Morgan TM, Feng FY, Hamstra DA, Schipper MJ, Collins SP, Spratt DE BJU Int. 2017 Jul
Natural History of 'Second' Biochemical Failure Following Salvage Radiation Therapy for Prostate Cancer: A Multi-Institution Study.
Tumati V, Jackson WC, Abugharib AE, Raj G, Roehrborn C, Lotan Y, Courtney K, Bagrodia A, Gahan JC, Zumsteg ZS, Folkert MR, Laine AM, Hannan R, Spratt DE, Desai NB BJU Int. 2017 Jun
Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival.
Abugharib A, Jackson WC, Tumati V, Dess RT, Lee JY, Zhao SG, Soliman M, Zumsteg ZS, Mehra R, Feng FY, Morgan TM, Desai N, Spratt DE J. Urol. 2017 Mar 197 3 Pt 1 662-668
Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study.
Jackson WC, Desai NB, Abugharib AE, Tumati V, Dess RT, Lee JY, Zhao SG, Soliman M, Folkert M, Laine A, Hannan R, Zumsteg ZS, Sandler H, Hamstra DA, Montgomery JS, Miller DC, Kozminski MA, Hollenbeck BK, Hearn JW, Palapattu G, Tomlins SA, Mehra R, Morgan TM, Feng FY, Spratt DE BJU Int. 2017 Jan
Genomic characterization of response to chemoradiation in urothelial bladder cancer.
Desai NB, Scott SN, Zabor EC, Cha EK, Hreiki J, Sfakianos JP, Ramirez R, Bagrodia A, Rosenberg JE, Bajorin DF, Berger MF, Bochner BH, Zelefsky MJ, Kollmeier MA, Ostrovnaya I, Al-Ahmadie HA, Solit DB, Iyer G Cancer 2016 Aug
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.
Al-Ahmadie HA, Iyer G, Lee BH, Scott SN, Mehra R, Bagrodia A, Jordan EJ, Gao SP, Ramirez R, Cha EK, Desai NB, Zabor EC, Ostrovnaya I, Gopalan A, Chen YB, Fine SW, Tickoo SK, Gandhi A, Hreiki J, Viale A, Arcila ME, Dalbagni G, Rosenberg JE, Bochner BH, Bajorin DF, Berger MF, Reuter VE, Taylor BS, Solit DB Nat. Genet. 2016 Feb